Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Clinical trial NCT06751524 · AVAILABLE

Trial details

NCT number: NCT06751524
Sponsor: Agenus Inc.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Colorectal Cancer (CRC)Pancreatic Cancer Non-Small Cell Lung Cancer (NSCLC)Hepatocellular Carcinoma (HCC)Melanoma Sarcoma Ovarian Cancer Prostate Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.